CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mallinckrodt LLC v. Taro Pharmaceutical Industries Ltd.

1:13-cv-00494

Overview

Case Number 1:13-cv-00494
Filing Date 2013-03-28
Status Terminated
Termination Date 2014-10-06
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Taro Pharmaceuticals USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Taro Pharmaceutical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Mallinckrodt LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Nuvo Research Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Miscellaneous

Mallinckrodt Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2014-12-23
1:14-cv-07992

HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.

Asserted Patent
Status: NJD
U.S. District Court 2013-12-19
1:13-cv-02044

IGI Laboratories Inc. v. Mallinckrodt LLC

Asserted Patent
Status: DED
U.S. District Court 2012-08-30
1:12-cv-01087

Mallinckrodt LLC v. Lupin Ltd

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8217078
Treatment of pain with topical diclofenac
Filed: 2010-10-28
Issued: 2012-07-10
Active (3.9 yrs remaining)
Expires: 2030-10-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

7

Granted

0

Denied

0

Pending / Review

12

Motions by Category

Procedural / Extension Motion 5 Motion to Dismiss 7

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME to file Answering Brief to Motion to Dismiss Claims or, in the Alternative, to Transfer to the Southern District of New York (D.I. 12...
Entry #20 • 2014-08-26 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file their Answering Brief to Taro's Motion to Dismiss or, in the Alternative, to Transfer to the Southern District...
Entry #19 • 2014-07-25 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file their Answering Brief to Taro's Motion to Dismiss Claims or, in the Alternative, to Transfer to the Southern D...
Entry #18 • 2014-06-26 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME Plaintiffs shall file their Answering Brief to Taro's Motion To Dismiss Claims or, In the Alternative, to Transfer to the Southern Di...
Entry #17 • 2014-05-27 Document →
Motion to Dismiss Pending / Under Review
STIPULATION TO EXTEND TIME to file answering brief to motion to dismiss or transfer to May 28, 2014 - filed by Mallinckrodt Inc., Mallinckrodt LLC, Nuvo Researc...
Entry #16 • 2014-04-25 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss, or in the Alternative, to Transfer to the Southern District of New York - filed by Taro Pharmaceutical USA Inc.. (Dorsney, Kenneth) Modified ...
Entry #12 • 2014-04-09 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT - filed against Taro Pharmaceutical Industries Ltd., Taro Pharmaceutical USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350.00, receipt number 0311-1258519.) - filed by Mallinckrodt LLC, Mallinckrodt Inc., Nuvo Research Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 03/29/2013)

Entry #1 • 2013-03-28
1
Pleading / Complaint

COMPLAINT - filed against Taro Pharmaceutical Industries Ltd., Taro Pharmaceutical USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350.00, receipt number 0311-1258519.) - filed by Mallinckrodt LLC, Mallinckrodt Inc., Nuvo Research Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 03/29/2013)

Entry #1 • 2013-03-28
2
Pleading / Complaint

COMPLAINT - filed against Taro Pharmaceutical Industries Ltd., Taro Pharmaceutical USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350.00, receipt number 0311-1258519.) - filed by Mallinckrodt LLC, Mallinckrodt Inc., Nuvo Research Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(rwc) (Entered: 03/29/2013)

Entry #1 • 2013-03-28
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (rwc) (Entered: 03/29/2013)

Entry #2 • 2013-03-28
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/12/13. Date of Expiration of Patent: 7/10/29.Thirty Month Stay Deadline: 1/16/2015 & 1/15/2015. (rwc) Modified on 3/29/2013 (rwc). (Entered: 03/29/2013)

Entry #3 • 2013-03-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc